Hyderabad: Eli Lilly and Company, a multinational pharmaceutical company, announced plans to establish a new global ...

The ₹8,500 crore order from Eli Lilly and Company is a testament to Remedium Lifecares capabilities and its growing ...

Johnson & Johnson stock (NYSE: JNJ) lost about 7% in 2024, underperforming the broader S&P 500 index, which gained 23% for ...

Weight loss goals may be at the forefront of many New Year's resolutions, which could push the exuberance for Eli Lilly LLY ...

Colulintide is under clinical development by Eli Lilly and Co and currently in Phase I for Obesity. According to GlobalData, Phase I drugs for Obesity have a 59% phase transition success rate (PTSR) ...

LY-4052031 is under clinical development by Eli Lilly and Co and currently in Phase I for Ovarian Cancer. According to GlobalData, Phase I drugs for Ovarian Cancer have a 73% phase transition success ...

Parvinder Singh transformed Ranbaxy into a global pharmaceutical powerhouse, but the empire he built crumbled under his sons’ ...

Indian pharmaceutical company Remedium Lifecare Limited, listed on the BSE Code 539561, has recently made a significant achievement. The company has received a massive order worth ₹8,500 crore from ...

Eli Lilly will seek to have Mounjaro listed on the scheme this year. If successful, it would mean taxpayer subsidies for the ...

It considers the safety, efficacy and, most importantly, the cost-benefit of new pharmaceuticals ... set by Eli Lilly for the use of Mounjaro in type 2 diabetes is any marker, the company is ...

The search for effective Alzheimer’s treatments is emerging as a promising market, capturing the attention of major ...

Political and economic uncertainty hangs over the industry, while major bets on metabolic and immune disease drug research are set to play out.